Rare variants in the TREX1 gene and susceptibility to autoimmune diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Barizzone, Nadia ^a   Monti, Sara ^a   Mellone, Simona ^a   Godi, Michela ^a   Marchini, Maurizio ^b   Scorza, Raffaella ^b   Danieli, Maria G ^c   D'Alfonso, Sandra ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; EXODEOXYRIBONUCLEASE III; GLUTAMIC ACID; LYSINE; METHIONINE; VALINE; EXODEOXYRIBONUCLEASE; PHOSPHOPROTEIN; THREE PRIME REPAIR EXONUCLEASE 1;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; COMPUTER MODEL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PROTEIN FUNCTION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREX1 GENE; GENETICS; MUTATION; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EXODEOXYRIBONUCLEASES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MUTATION; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84886572466     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/471703     Document Type: Article

References (16)

1. Chowdhury D., Beresford P. J., Zhu P., Zhang D., Sung J.-S., Demple B., Perrino F. W., Lieberman J., The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme a-mediated cell death. Molecular Cell 2006 23 1 133 142 2-s2.0-33745501366 10.1016/j.molcel. 2006.06.005 (Pubitemid 43963449)
2. Christmann M., Tomicic M. T., Aasland D., Berdelle N., Kaina B., Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced dna damage. Nucleic Acids Research 2010 38 19 6418 6432 2-s2.0-78049369870 10.1093/nar/gkq455
3. Morita M., Stamp G., Robins P., Dulic A., Rosewell I., Hrivnak G., Daly G., Lindahl T., Barnes D. E., Gene-targeted mice lacking the TREX1 (DNase III) 3′→5′ DNA exonuclease develop inflammatory myocarditis. Molecular and Cellular Biology 2004 24 15 6719 6727 2-s2.0-3242672339 10.1128/MCB.24.15.6719-6727.2004 (Pubitemid 38944351)
4. Lee-Kirsch M. A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.-A., de Silva U., Bailey S. L., Witte T., Vyse T. J., Kere J., Pfeiffer C., Harvey S., Wong A., Koskenmies S., Hummel O., Rohde K., Schmidt R. E., Dominiczak A. F., Gahr M., Hollis T., Perrino F. W., Lieberman J., Hübner N., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nature Genetics 2007 39 9 1065 1067 2-s2.0-34548327158 10.1038/ng2091 (Pubitemid 47340647)
5. de Vries B., Steup-Beekman G. M., Haan J., Bollen E. L., Luyendijk J., Frants R. R., Terwindt G. M., van Buchem M. A., Huizinga T. W. J., van den Maagdenberg A. M. J. M., Ferrari M. D., TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Annals of the Rheumatic Diseases 2010 69 10 1886 1887 2-s2.0-77955626335 10.1136/ard.2009.114157
6. Hedrich C. M., Fiebig B., Hauck F. H., Sallmann S., Hahn G., Pfeiffer C., Heubner G., Lee-Kirsch M. A., Gahr M., Chilblain lupus erythematosus-a review of literature. Clinical Rheumatology 2008 27 10 1341
7. Richards A., van den Maagdenberg A. M. J. M., Jen J. C., Kavanagh D., Bertram P., Spitzer D., Liszewski M. K., Barilla-Labarca M.-L., Terwindt G. M., Kasai Y., McLellan M., Grand M. G., Vanmolkot K. R. J., de Vries B., Wan J., Kane M. J., Mamsa H., Schäfer R., Haan J., de Jong P. T. V. M., Storimans C. W., van Schooneveld M. J., Oosterhuis J. A., Gschwendter A., Dichgans M., Kotschet K. E., Hodgkinson S., Hardy T. A., Delatycki M. B., Hajj-Ali R. A., Kothari P. H., Nelson S. F., Frants R. R., Baloh R. W., Ferrari M. D., Atkinson J. P., C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nature Genetics 2007 39 9 1068 1070 2-s2.0-34548334617 10.1038/ng2082 (Pubitemid 47340644)
8. Soong B., Liao Y., Tu P., A homozygous NOTCH3 mutation p.R544C and a heterozygous TREX1 variant p.C99MfsX3 in a family with hereditary small vessel disease of the brain. Journal of the Chinese Medical Association 2013 76 6 319 324
9. Ramantani G., Kohlhase J., Hertzberg C., Micheil Innes A., Engel K., Hunger S., Borozdin W., Mah J. K., Ungerath K., Walkenhorst H., Richardt H.-H., Buckard J., Bevot A., Siegel C., Von Stülpnagel C., Ikonomidou C., Thomas K., Proud V., Niemann F., Wieczorek D., Häusler M., Niggemann P., Baltaci V., Conrad K., Lebon P., Lee-Kirsch M. A., Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis & Rheumatism 2010 62 5 1469 1477 2-s2.0-77951737544 10.1002/art.27367
10. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism 1997 40 9 1725 2-s2.0-0031229830
11. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., Daniels T. E., Fox P. C., Fox R. I., Kassan S. S., Pillemer S. R., Talal N., Weisman M. H., Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases 2002 61 6 554 558 2-s2.0-0036092482 10.1136/ard.61.6.554 (Pubitemid 34539104)
12. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis & Rheumatism 1980 23 5 581 590 2-s2.0-0018887574
13. de Silva U., Choudhury S., Bailey S. L., Harvey S., Perrino F. W., Hollis T., The crystal structure of TREX1 explains the 3′ nucleotide specificity and reveals a polyproline II helix for protein partnering. The Journal of Biological Chemistry 2007 282 14 10537 10543 2-s2.0-34249848019 10.1074/jbc.M700039200 (Pubitemid 47093395)
14. Lehtinen D. A., Harvey S., Mulcahy M. J., Hollis T., Perrino F. W., The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. The Journal of Biological Chemistry 2008 283 46 31649 31656 2-s2.0-57649134251 10.1074/jbc.M806155200
15. Koumakis E., Giraud M., Dieudè P., Candidate gene study in systemic sclerosis identifies a rare and functional variant on the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis & Rheumatism 2012 64 8 2746 2752 10.1002/art.34490
16. Namjou B., Kothari P. H., Kelly J. A., Glenn S. B., Ojwang J. O., Adler A., Alarcón-Riquelme M. E., Gallant C. J., Boackle S. A., Criswell L. A., Kimberly R. P., Brown E., Edberg J., Stevens A. M., Jacob C. O., Tsao B. P., Gilkeson G. S., Kamen D. L., Merrill J. T., Petri M., Goldman R. R., Vila L. M., Anaya J.-M., Niewold T. B., Martin J., Pons-Estel B. A., Sabio J. M., Callejas J. L., Vyse T. J., Bae S.-C., Perrino F. W., Freedman B. I., Scofield R. H., Moser K. L., Gaffney P. M., James J. A., Langefeld C. D., Kaufman K. M., Harley J. B., Atkinson J. P., Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes and Immunity 2011 12 4 270 279 2-s2.0-79958015275 10.1038/gene.2010.73